quinacrine has been researched along with Diabetic Retinopathy in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, J | 1 |
| Umeda, F | 1 |
| Wasada, T | 1 |
| Ibayashi, H | 1 |
1 other study available for quinacrine and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus.
Topics: Adult; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Imidazoles; Indomethacin; Male; Midd | 1984 |